基本信息
views: 247
Career Trajectory
Bio
The overall goal of my research is to advance the integration of immunotherapy within comprehensive cancer care, as a complementary modality to surgery, chemo and radiotherapy. My group develops new methods of using ex vivo-educated dendritic cells, DC-activated T cells, combinatorial adjuvants and checkpoint blockers, to promote selectively accumulation of type-1 immune cells (CTLs, Th1 and NK cells) in tumor lesions, without amplifying pre-existing Treg- and MDSC responses, in order to enhance local immune surveillance and enhance overall therapeutic outcomes. Our current projects include:
Development and clinical evaluation of therapeutic vaccines involving different subsets of “polarized” DCs (colorectal cancer, ovarian cancer, prostate cancer, melanoma, hematologic malignancies)
Development and clinical evaluation of adoptive T cell therapies (ACT) using ex vivo-induced polyclonal CTLs (ovarian- & colorectal cancers and melanoma)
Development and clinical evaluation of combinatorial approaches to enhance the effectiveness of vaccines, ACT and checkpoint blockers, but reprogramming tumor microenvironments for enhanced CTL infiltration and modulating intratumoral expression of PD-L1, PD-L2 and other checkpoints (colorectal cancer, ovarian cancer, prostate cancer, melanoma, bladder cancer, HPV-associated cancers)
Development of combinatorial adjuvants to modulate DC functions in situ
Counteracting cancer-related immunosuppressive mechanisms and their use in transplantation and autoimmunity
Role of the immune system in the effectiveness of oncolytic virotherapies
Role of the immune system in the effectiveness of chemotherapy and radiotherapy of cancer
Interplay between psychologic stress and cancer immunity These interdisciplinary projects involving multiple clinical and laboratory teams, have been advanced as parts of the as multiple NIH-, DOD-, pharma and biotech-funded grants and program projects (single- and multi-institution P01s and P50/SPOREs; where I have been serving as the overall PI, overall co-PI or a Project Leader) and focusing on the therapy of melanoma, colon cancer, prostate cancer, ovarian cancer, and hematologic malignancies. Our current work includes phase I/II and phase II clinical testing of the resulting paradigms and methods in cancer patients, and development of similar treatments for patients with premalignant lesions and chronic infections resistant to standard forms of treatment.
Research Interests
Papers共 403 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jayasree Krishnan, Archit Patel, Arya Mariam Roy, Malak Alharbi,Ankita Kapoor, Nicole Held, Anumita Chakraborty, Ahmed Salman, Kayla Catalfamo,Kristopher Attwood,Thaer Khoury,Song Yao,
Journal of Clinical Oncologyno. 16_suppl (2024)
Bowen Dong,Nataša Obermajer,Takemasa Tsuji,Junko Matsuzaki, Cindy Bonura,Henry Withers,Mark Long,Colin Chavel,Scott H. Olejniczak, Hans Minderman,Robert P. Edwards,Walter J. Storkus,
Cancer Researchno. 6_Supplement (2024): 3966-3966
Bowen Dong,Natasa Obermajer,Takemasa Tsuji,Junko Matsuzaki, Cindy M Bonura, Cindy Sander, Henry Withers,Mark D Long, Colin Chavel, Scott H Olejniczak,Hans Minderman,John M Kirkwood,
Cancer immunology research (2024)
Robert Seager, Heidi Ko,Sarabjot Pabla,Maria-Fernanda Senosain,Pawel Kalinski,Erik Van Roey, Shuang Gao, Kyle Strickland, Rebecca Previs, Mary Nesline, Stephanie Hastings, Shengle Zhang,
Cancer Researchno. 9_Supplement (2024): PO4-25
Shipra Gandhi, Cayla Jones,Mateusz Opyrchal, Ronald Slomba,Kristopher Attwood,Jianmin Wang,Eduardo Cortes Gomez, Tracey O'Connor,Ellis Levine,Pawel Kalinski
Cancer Researchno. 9_Supplement (2024): PO1-18
Jessica N. Filderman, Jennifer L. Taylor,Jianmin Wang,Yali Zhang,Prashant Singh,Mark A. Ross,Simon C. Watkins, Ayah Nedal Al Bzour,Lilit Karapetyan,Pawel Kalinski,Walter J. Storkus
JOURNAL OF PERSONALIZED MEDICINEno. 5 (2024): 481
Daniel Alvarado, Jennifer Peresie, Adam Brinkman, Cheryl Allen,Weijian Jiang,Pawel Kalinski, Tiffany Tanaka,Elizabeth Griffiths, Michael Nemeth
Cancer Researchno. 6_Supplement (2024): 6744-6744
Shipra Gandhi,Mateusz Opyrchal, Cayla Ford, Ronald Slomba,Kristopher Attwood,Tracey O'Connor,Ellis Levine,Pawel Kalinski
CANCER RESEARCHno. 5 (2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn